Common Ozempic side effects, such as nausea, diarrhea, constipation, vomiting, and stomach pain, often start in the first days or weeks of treatment or after a dose increase. For many people, they improve within a few days to several weeks, but persistent, severe, or worsening symptoms should be reviewed by a clinician.
Wondering if semaglutide is right for you? Take the 3-min clinical quiz.
See if you qualify →How long do Ozempic side effects usually last?
Ozempic side effects often last a few days to several weeks, especially when the body is adjusting to semaglutide. The label’s adult type 2 diabetes studies used dose escalation, with an FDA-approved starting dose of 0.25 mg once weekly for 4 weeks before increasing to 0.5 mg once weekly 1.
Ozempic (semaglutide, a glucagon-like peptide-1 receptor agonist, or GLP-1 receptor agonist) can slow stomach emptying and affect appetite signals. That is why symptoms often appear when treatment starts or after a dose increase 1, 6.
Why side effects often appear when starting or increasing the dose
Semaglutide activates GLP-1 receptors. This helps with blood sugar regulation in type 2 diabetes, but it can also slow how quickly food leaves the stomach. A controlled trial found that once-weekly semaglutide delayed first-hour gastric emptying, which can feel like nausea, fullness, burping, bloating, or reflux 6.
Why some symptoms can last longer for some people
Side effects may last longer if symptoms return with each dose increase, if constipation builds over time, or if a person has a history of reflux, gastroparesis-like symptoms, gallbladder disease, dehydration risk, or other digestive conditions. The Ozempic label also warns about pancreatitis, gallbladder disease, kidney injury related to dehydration, diabetic retinopathy complications, and hypoglycemia when used with insulin or sulfonylureas 1.
Which Ozempic side effects are most common?
The most common Ozempic side effects are digestive: nausea, vomiting, diarrhea, abdominal pain, and constipation. In Ozempic placebo-controlled trials, these occurred more often with semaglutide than placebo 1.
| Side effect | Why it can happen | Typical pattern |
|---|---|---|
| Nausea | Slower stomach emptying and appetite signaling | Often starts early or after a dose increase; often improves with time |
| Vomiting | Nausea, delayed gastric emptying, or eating past fullness | May be short-lived, but persistent vomiting needs clinician review |
| Diarrhea | Gut motility and fluid shifts can change | Often occurs early; dehydration risk rises if severe |
| Constipation | Slower gut movement and reduced food intake | Can build over days to weeks and may last longer than nausea |
| Abdominal pain, bloating, burping, reflux | Fullness and slower gastric emptying | May flare with larger meals, high-fat meals, or dose changes |
| Fatigue, dizziness, appetite changes | Lower intake, dehydration, blood sugar changes, or medication effects | Should be reviewed if severe, persistent, or linked with low blood sugar symptoms |
In the SUSTAIN clinical trial program for semaglutide in type 2 diabetes, gastrointestinal adverse events were a major reason some participants stopped treatment, even though many events were mild or moderate 4. Individual results vary.
Why does Ozempic make some people feel sick?
Semaglutide works by mimicking GLP-1, a hormone involved in insulin release, glucagon suppression, appetite, and stomach emptying. These same effects explain why some people feel sick, especially during the first month or after a higher dose 1, 6.
When food leaves the stomach more slowly, a normal meal may feel too large. That can cause nausea, pressure, reflux, burping, or vomiting. If vomiting or diarrhea leads to dehydration, kidney problems can occur; the Ozempic label notes postmarketing reports of acute kidney injury, often in people with nausea, vomiting, diarrhea, or dehydration 1.
Side effects may return after dose escalation because the body is adjusting again. This is one reason clinician-guided dose changes matter: a provider can help decide whether symptoms are expected, need monitoring, or need a treatment change.
What is a realistic side-effect timeline by symptom?
A realistic side-effect timeline is measured in days to weeks, not hours alone. Some symptoms can appear after the first dose, while others build over the first several weeks or return during dose escalation 1.
| Symptom | When it may start | How long it may last | When to get help |
|---|---|---|---|
| Nausea | First days to weeks; often after dose increases | Often improves over days to several weeks | If severe, worsening, or stopping you from drinking fluids |
| Vomiting | Early or after dose increases | May be brief; persistent vomiting is not something to ignore | Urgent care if repeated, severe, or with dehydration |
| Diarrhea | Early weeks or after dose changes | Often improves, but can recur | If severe, bloody, or causing dizziness or dehydration |
| Constipation | Can build over days to weeks | May last longer if food and fluid intake drop | If severe pain, vomiting, or inability to pass stool occurs |
| Stomach pain, bloating, reflux | Early weeks or after larger meals | May improve as meal size and stomach emptying adjust | Urgent care for severe or persistent abdominal pain |
| Fatigue or dizziness | Any time, often with lower intake or dehydration | Often improves when intake and hydration stabilize | If fainting, confusion, severe weakness, or low blood sugar symptoms occur |
The FDA labels for Ozempic and Wegovy both emphasize dose escalation to improve gastrointestinal tolerability, though the labeled dose schedules differ because the products have different approved uses 1, 2. Ozempic is FDA-approved for adults with type 2 diabetes for glycemic control and to reduce certain cardiovascular risks in eligible patients; it is not FDA-approved specifically for weight loss 1. Wegovy is the FDA-approved semaglutide brand for chronic weight management in eligible patients 2.
3-min quiz
Considering semaglutide with clinician guidance?
Chia offers compounded semaglutide injection through a 100% online medical evaluation. A licensed provider reviews your health history and prescribes only when clinically appropriate; a prescription is never guaranteed. Compounded medications are not FDA-approved.
How long can side effects last after stopping Ozempic?
Semaglutide does not leave the body right away. The Ozempic label reports an elimination half-life of about 1 week, and semaglutide can remain in circulation for about 5 weeks after the last dose 1.
Because of that long half-life, nausea, appetite changes, constipation, or diarrhea may not stop immediately after the last injection. Stopping or changing treatment should be clinician-guided, especially for people using Ozempic for type 2 diabetes or people taking insulin or sulfonylureas, because blood sugar can change 1.
What can influence how long Ozempic side effects last?
Dose escalation, meal pattern, other medications, and personal health history can all affect how long side effects last. The same symptom can be mild for one person and disruptive for another.
- Dose and escalation speed: side effects often appear when starting or increasing semaglutide because GLP-1 effects on the gut become stronger 1.
- Meal size and fat intake: high-fat or large meals can worsen fullness, reflux, and nausea when stomach emptying is slower 6.
- Hydration and alcohol: vomiting or diarrhea can cause dehydration; alcohol may add nausea, reflux, or blood sugar concerns.
- Other medications: insulin and sulfonylureas can raise hypoglycemia risk when used with Ozempic 1.
- Health history: pancreatitis history, gallbladder disease, kidney disease, diabetic retinopathy, and severe digestive symptoms deserve careful clinician review 1.
- Medication access and support: people may tolerate therapy better when side effects are discussed early and dose changes are supervised.
For patients comparing GLP-1 options, our providers may also discuss tirzepatide, another incretin-based medication, when clinically appropriate. The right choice depends on medical history, goals, contraindications, side effects, and provider judgment.
When should you contact a clinician about Ozempic side effects?
Contact a clinician if Ozempic side effects do not improve, interfere with daily life, or feel severe. Some symptoms need urgent care because they may signal dehydration, pancreatitis, hypoglycemia, allergic reaction, gallbladder disease, or another serious problem 1.
Ozempic carries an FDA boxed warning about thyroid C-cell tumors seen in rodents. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma or in people with multiple endocrine neoplasia syndrome type 2 1.
Why do some people quit Ozempic?
Some people stop Ozempic because digestive side effects affect quality of life. In semaglutide trials, gastrointestinal adverse events were among the most common adverse events and sometimes led to discontinuation 3, 4.
Cost, access, shortages, and changing goals can also matter. A clinician may discuss slower escalation, symptom management, a different GLP-1 medication, a non-GLP-1 option, or stopping treatment. For some patients, programs that combine GLP-1 care with supportive treatments, such as Chia’s Weight + Energy or Weight + Muscle protocols, may be considered after an online evaluation.
What if you are considering semaglutide treatment through Chia?
At Chia, we offer compounded semaglutide injection, not brand-name Ozempic. Plans currently start at $249/mo, and treatment requires a licensed-provider evaluation through our online visit; prescribing is never guaranteed.
Here is how care works: you complete a short online health questionnaire, then a licensed US provider reviews your history, goals, medications, and contraindications. If treatment is appropriate, medication is compounded in the US by a state-licensed 503A pharmacy and shipped to your door. Dosing is provider-guided and adjusted over time, including microdosing plans for semaglutide when clinically appropriate.
| Option | What Chia offers | Important notes |
|---|---|---|
| Brand-name Ozempic | Chia does not offer brand-name Ozempic | Ozempic is FDA-approved for adults with type 2 diabetes for glycemic control and certain cardiovascular risk reduction uses 1. |
| Compounded semaglutide injection | Available through Chia | Compounded medications are not FDA-approved; a licensed provider must decide whether treatment is clinically appropriate. |
| Microdosing plan | Available for semaglutide when clinically appropriate | Provider-guided only; do not change dosing on your own. |
If you are new to GLP-1 medications, side-effect planning is part of care. Our providers review red flags, medication interactions, and follow-up needs through the patient portal so you are not guessing alone.
3-min quiz
Start with an online eligibility review
If you are considering compounded semaglutide, you can start with Chia’s online eligibility quiz. A licensed provider reviews your information and prescribes only when clinically appropriate. Compounded medications are not FDA-approved, and a prescription is not guaranteed.
Frequently asked questions about how long Ozempic side effects last
Often, yes. Many common digestive side effects improve as the body adjusts, but some people have symptoms that persist, worsen, or return after dose increases. A clinician should review severe or ongoing symptoms.
Ozempic nausea often starts in the first days or weeks and may improve within days to several weeks. It can return after a dose increase. Severe nausea or vomiting that prevents fluid intake needs medical guidance.
Yes, feeling nauseated, full, bloated, or constipated after a dose increase can happen because semaglutide affects stomach emptying and appetite. Still, symptoms should be tolerable and improving, not severe or worsening.
They can for some people, especially constipation, reflux, or recurring nausea during dose escalation. Symptoms lasting months should be discussed with a clinician to review dose, diet pattern, hydration, other medications, and whether treatment still fits.
Semaglutide has a half-life of about 1 week and can remain in the body for about 5 weeks after the last dose. This is why side effects may not stop immediately after stopping.
Do not stop, skip, or change Ozempic or semaglutide dosing without clinician guidance unless you are having emergency symptoms and need urgent care. A provider can help decide whether to monitor, adjust, pause, or change treatment.
Compounded semaglutide contains semaglutide as the active ingredient, so GLP-1-type side effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort may occur. Compounded drugs are not FDA-approved and do not have FDA-evaluated outcomes data like brand-name products.
References
- 1.Novo Nordisk. Ozempic (semaglutide) injection, for subcutaneous use: Prescribing Information. U.S. Food and Drug Administration, 2025.
- 2.Novo Nordisk. Wegovy (semaglutide) injection, for subcutaneous use: Prescribing Information. U.S. Food and Drug Administration, 2025.
- 3.Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 2021.
- 4.Aroda VR, Ahmann A, Cariou B, et al. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials. Diabetes, Obesity and Metabolism, 2019.
- 5.Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 2016.
- 6.Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes, Obesity and Metabolism, 2018.
- 7.U.S. Food and Drug Administration. FDA alerts health care professionals, compounders and patients of dosing errors associated with compounded injectable semaglutide products. U.S. Food and Drug Administration, 2024.
- 8.American Diabetes Association Professional Practice Committee. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes—2026. Diabetes Care, 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if semaglutide is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
